Cargando…

Prevention of liver tumor formation in woodchucks with established hepatocellular carcinoma by treatment with cationic liposome-DNA complexes

BACKGROUND: Approximately 250 million people worldwide are chronically infected with hepatitis B virus (HBV) and more than half of the hepatocellular carcinoma (HCC) cases are attributed to this infection. As HCC has a high mortality rate, and current treatment options are remarkably limited, the de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fairman, Jeffery, Liu, Katherine H., Menne, Stephan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5339946/ https://www.ncbi.nlm.nih.gov/pubmed/28264666 http://dx.doi.org/10.1186/s12885-017-3163-2

Ejemplares similares

Application of the woodchuck animal model for the treatment of hepatitis B virus-induced liver cancer
por: Suresh, Manasa, et al.
Publicado: (2021)

Innate and adaptive immunity associated with resolution of acute woodchuck hepatitis virus infection in adult woodchucks
por: Suresh, Manasa, et al.
Publicado: (2019)

Recent Drug Development in the Woodchuck Model of Chronic Hepatitis B
por: Suresh, Manasa, et al.
Publicado: (2022)

Agonistic Activation of Cytosolic DNA Sensing Receptors in Woodchuck Hepatocyte Cultures and Liver for Inducing Antiviral Effects
por: Suresh, Manasa, et al.
Publicado: (2021)

Combination Treatment with the Vimentin-Targeting Antibody hzVSF and Tenofovir Suppresses Woodchuck Hepatitis Virus Infection in Woodchucks
por: Korolowicz, Kyle E., et al.
Publicado: (2021)

Enzyme‐altered Liver Cell Foci in Woodchucks Infected with Woodchuck Hepatitis Virus
por: Abe, Kenji, et al.
Publicado: (1988)

Involvement of Innate Immune Receptors in the Resolution of Acute Hepatitis B in Woodchucks
por: Suresh, Manasa, et al.
Publicado: (2021)

Establishment and Characterization of a Woodchuck Hepatocellular Carcinoma Cell Line (WH44KA)
por: Abe, Kenji, et al.
Publicado: (1988)

Efficacy of an Inhibitor of Hepatitis B Virus Expression in Combination With Entecavir and Interferon‐α in Woodchucks Chronically Infected With Woodchuck Hepatitis Virus
por: Menne, Stephan, et al.
Publicado: (2020)

Immune Effects of Cryoablation in Woodchuck Hepatocellular Carcinoma
por: Mauda-Havakuk, Michal, et al.
Publicado: (2023)

Effective, Broad Spectrum Control of Virulent Bacterial Infections Using Cationic DNA Liposome Complexes Combined with Bacterial Antigens
por: Ireland, Robin, et al.
Publicado: (2010)

Molecular characterization of woodchuck IFI16 and AIM2 and their expression in woodchucks infected with woodchuck hepatitis virus (WHV)
por: Yan, Qi, et al.
Publicado: (2016)

Suitability of the woodchuck HCC as a preclinical model for evaluation of intra‐arterial therapies
por: Kim, Alexander Y., et al.
Publicado: (2020)

AIC649 Induces a Bi-Phasic Treatment Response in the Woodchuck Model of Chronic Hepatitis B
por: Paulsen, Daniela, et al.
Publicado: (2015)

Cryo-EM structures of human hepatitis B and woodchuck hepatitis virus small spherical subviral particles
por: Liu, Haitao, et al.
Publicado: (2022)

Treatment with the Immunomodulator AIC649 in Combination with Entecavir Produces Antiviral Efficacy in the Woodchuck Model of Chronic Hepatitis B
por: Korolowicz, Kyle E., et al.
Publicado: (2021)

Liver‐Targeted Toll‐Like Receptor 7 Agonist Combined With Entecavir Promotes a Functional Cure in the Woodchuck Model of Hepatitis B Virus
por: Korolowizc, Kyle E., et al.
Publicado: (2019)

The Genome Sequence of the Eastern Woodchuck (Marmota monax) – A Preclinical Animal Model for Chronic Hepatitis B
por: Alioto, Tyler S., et al.
Publicado: (2019)

Safety and efficacy of anti-PD-L1 therapy in the woodchuck model of HBV infection
por: Balsitis, Scott, et al.
Publicado: (2018)

Ovarian teratoma in a woodchuck (Marmota monax) with hepatocellular carcinoma: radiologic and pathologic features
por: Zeng, Johnathan, et al.
Publicado: (2020)

Antiviral Efficacy and Host Immune Response Induction during Sequential Treatment with SB 9200 Followed by Entecavir in Woodchucks
por: Suresh, Manasa, et al.
Publicado: (2017)

Antiviral Efficacy and Host Innate Immunity Associated with SB 9200 Treatment in the Woodchuck Model of Chronic Hepatitis B
por: Korolowicz, Kyle E., et al.
Publicado: (2016)

Imaging of Tumor-Associated Vascular Prostate-Specific Membrane Antigen in Woodchuck Model of Hepatocellular Carcinoma
por: Sergeeva, Olga, et al.
Publicado: (2022)

Intrahepatic Transcriptional Signature Associated with Response to Interferon-α Treatment in the Woodchuck Model of Chronic Hepatitis B
por: Fletcher, Simon P., et al.
Publicado: (2015)

Preparation, characterization, and efficient transfection of cationic liposomes and nanomagnetic cationic liposomes
por: Samadikhah, Hamid Reza, et al.
Publicado: (2011)

Correction: Intrahepatic Transcriptional Signature Associated with Response to Interferon-α Treatment in the Woodchuck Model of Chronic Hepatitis B
por: Fletcher, Simon P., et al.
Publicado: (2016)

Toll-Like Receptor 7 Agonist RG7854 Mediates Therapeutic Efficacy and Seroconversion in Woodchucks With Chronic Hepatitis B
por: Wildum, Steffen, et al.
Publicado: (2022)

Disturbances in the Glutathione/Ophthalmate Redox Buffer System in the Woodchuck Model of Hepatitis Virus-Induced Hepatocellular Carcinoma
por: Andres Ibarra, Rafael, et al.
Publicado: (2011)

Therapeutic Vaccination in Chronic Hepatitis B: Preclinical Studies in the Woodchuck
por: Kosinska, Anna D., et al.
Publicado: (2010)

Persistence of the Recombinant Genomes of Woodchuck Hepatitis Virus in the Mouse Model
por: Pan, Danzhen, et al.
Publicado: (2015)

A novel hepatovirus identified in wild woodchuck Marmota himalayana
por: Yu, Jie-mei, et al.
Publicado: (2016)

Imaging, Pathology, and Immune Correlates in the Woodchuck Hepatic Tumor Model
por: Mauda-Havakuk, Michal, et al.
Publicado: (2021)

Toll‐Like Receptor 8 Agonist GS‐9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis B
por: Daffis, Stephane, et al.
Publicado: (2020)

In Vitro CRISPR/Cas9 Transfection and Gene-Editing Mediated by Multivalent Cationic Liposome–DNA Complexes
por: Sousa, Diana A., et al.
Publicado: (2022)

Initial sites of hepadnavirus integration into host genome in human hepatocytes and in the woodchuck model of hepatitis B-associated hepatocellular carcinoma
por: Chauhan, R, et al.
Publicado: (2017)

Charge Conversion Polymer–Liposome Complexes to Overcome the Limitations of Cationic Liposomes in Mitochondrial-Targeting Drug Delivery
por: Shueng, Pei-Wei, et al.
Publicado: (2022)

Primary Seronegative but Molecularly Evident Hepadnaviral Infection Engages Liver and Induces Hepatocarcinoma in the Woodchuck Model of Hepatitis B
por: Mulrooney-Cousins, Patricia M., et al.
Publicado: (2014)

Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes
por: Rosada, Rogério S, et al.
Publicado: (2008)

Gene delivery into hepatic cells with ternary complexes of plasmid DNA, cationic liposomes and apolipoprotein E-derived peptide
por: Hattori, Yoshiyuki, et al.
Publicado: (2019)

Establishment of an Antiplasmodial Vaccine Based on PfRH5-Encoding RNA Replicons Stabilized by Cationic Liposomes
por: Fotoran, Wesley L., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hes4uddc1229jguk4ncm81hg22